The Belgium Financial Services and Markets Authority, acting under Article 78 of the Law of 21 November 2017, has suspended trading in Onward Medical’s financial instruments (ISIN NL0015000HT4) on Euronext Brussels at the company’s request from 23 October 2025 at 09:00 CET until the publication of a press release.
Belgium Financial Services and Markets Authority 2025-10-23
Belgium Financial Services and Markets Authority suspends trading in Onward Medical on Euronext Brussels pending company press release
The Belgium Financial Services and Markets Authority has suspended trading in Onward Medical’s financial instruments on Euronext Brussels at the company's request. This action, under Article 78 of the Law of 21 November 2017, is effective from 23 October 2025 at 09:00 CET until a press release is issued.